GenomiX SRL
GenomiX reported total assets of 343,875 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of GenomiX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +12 % Total assets +10 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GenomiX's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 12 Nov 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 28 Aug 2022
GenomiX's financial analysis
- Solvency74.3%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GenomiX
GenomiX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0757.949.684
- VAT number
- BE0757949684
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 10 Nov 2020
- Registered office
- 4031 Liège
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
GenomiX (SRL) has been based in Liège since 2020, active in: activities of holding companies. For 2025, it reports a net profit of 9,134 € and equity of 255,524 €; its revenue is not published. Its solvency stands at 74.3%, above the median of its sector (46.9%).
Companies similar to GenomiX
Companies in the same business, of comparable size and area, outside its group.
- Dr. C. Dielen Medical specialists activities Hove · balance sheet 344,016 €
- Penta Invest Joinery installation Saint-Ghislain · balance sheet 344,182 €
- Paca1 Activities of holding companies Sint-Martens-Latem · balance sheet 344,314 €
- Tim Holding Geetbets · balance sheet 344,359 €
- Dakwerken Scherpereel Gino Buying and selling of own real estate Kortrijk · balance sheet 343,389 €
- Collem Plant propagation Dilsen-Stokkem · balance sheet 343,384 €
- Ruhombru Beheer Activities of holding companies Turnhout · balance sheet 343,254 €
- Levin Activities of holding companies Houthalen-Helchteren · balance sheet 344,602 €
Frequently asked questions about GenomiX
What is the revenue of GenomiX?
GenomiX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GenomiX?
In Belgium, the VAT number is the company number prefixed with BE: BE0757949684 for GenomiX, if the company is VAT-registered. Its company number (CBE) is 0757.949.684.
Where is the registered office of GenomiX?
According to the CBE register, the registered office of GenomiX is in 4031 Liège.
What is the equity of GenomiX?
At the close of the 2025 financial year, the equity of GenomiX amounts to 255,524 €, a solvency of 74.3% of total assets.
Who manages GenomiX?
The register lists 4 active mandates at GenomiX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of GenomiX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →